查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2034925

全球人工血管市場：市場規模、佔有率和趨勢分析（2026-2032 年）

Implantable Port Market Size, Share, & Trends Analysis | Global | 2026-2032 | Includes: Power-Injectable Implantable and Non-Power-Injectable Ports
出版日期: | 出版商: iData Research Inc. | 英文 130 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球人工血管市場報告（至2032年）

2025年全球人工血管市場規模略高於4.3億美元。預計該市場將以3.0%的複合年成長率成長，到2032年達到約5.3億美元。

本報告涵蓋全球人工血管市場，包括用於長期血管通路的非電動和電動人工血管。

分析內容包括銷售量、平均售價 (ASP)、治療次數、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。

市場成長主要得益於電動注射式輸液港的普及、患者對全植入式血管通路的偏好以及持續的設計改進。然而，植入成本、手術負擔、通路不適以及其他靜脈通路裝置的競爭仍然限制了市場的進一步擴張。

市場概覽

全球人工血管市場包括皮下植入的長期靜脈通路裝置。這些產品常用於需要反覆輸液治療的患者，包括接受化療的癌症患者。

該市場包括電注射式和非電注射式植入端口。電注射式端口比傳統端口能承受更高的壓力，從而可以在電腦斷層掃描（CT）過程中注射造影劑。

如果患者植入的是傳統輸液港，之後需要進行特定的影像檢查流程，則可能需要移除該輸液港並更換為高壓輸液相容型輸液港。這促使許多醫療機構將高壓輸液技術作為首選方案。

持續的技術發展提升了人工血管的臨床性能，並拓展了其應用範圍。創新主要集中在抗菌材料、表面塗層、設計改進和替代置入策略等方面，使輸液港在特定適應症中成為比PICC和慢性中央靜脈導管（CVC）更具競爭力的選擇。

市場促進因素

高壓注射相容端口

高壓注塑相容連接埠是人工血管市場的主要驅動力。預計在預測期內，塑膠和混合材料高壓注塑相容端口的銷售將有所成長。

這些設備支援造影增強影像工作流程，在許多醫療機構中需求量很大。它們能夠承受高注射壓力，因此對於既需要輸液治療又需要影像的患者來說，是更靈活的選擇。

高壓輸液港的普及透過支撐對高附加價值產品的需求，有助於穩定市場動態。然而，隨著高壓輸液港成為標準治療方案，以及不同設備之間的價格差異持續縮小，預計這種影響將趨於正常化。

患者的偏好

患者的偏好也是重要的影響因素。接受化療的患者通常希望在治療期間保持積極的生活方式，而與體外靜脈通路裝置相比，人工血管在生活方式方面具有許多優勢。

與許多其他替代裝置不同，人工血管在不使用時從外部是看不見的。這使得它們對於希望在最大限度減少限制的同時保持日常活動的患者來說更具吸引力。

體外裝置可能會限制行動自由，並可能干擾游泳、淋浴設備或其他可能導致裝置移位或破壞其無菌性的活動。隨著人口老化，預計會有更多潛在的輸液港患者有需求且經濟能力選擇人工血管，而不是其他類型的輸液裝置。

技術和設計方面的改進

技術和設計上的進步推動了對人工血管的持續需求。製造商正致力於開發能夠降低感染風險、提高存取可靠性並支援長期使用的功能。

雖然與許多其他靜脈通路裝置相比，人工血管的感染風險已經較低，但各公司仍在投資抗菌材料、表面塗層和設計改進。

人們對包括針對特定腫瘤治療的周邊入路在內的替代植入策略的興趣日益濃厚，這反映了人們致力於減輕手術負擔的努力。這些改進符合臨床偏好，並有助於人工血管在與PICC和慢性中心靜脈導管的競爭中保持優勢。

市場限制

植牙手術

植入手術是人工血管市場的一個主要阻礙因素。輸液港植入通常需要在手術室進行麻醉和耗時的操作，因此比許多其他血管通路方法更昂貴。

對治療環境的需求可能會成為患者、醫療服務提供者和醫療系統的障礙。在對成本較為敏感的環境中，這個問題尤其重要，因為人們可能更傾向於選擇價格較低的輔助設備。

此外，植入手術可能會引起併發症，例如免疫系統較弱的患者發生感染疾病。雖然人工血管通常被認為感染風險較低，但手術相關風險仍是決定選擇輸液港植入或其他入路方式時需要考慮的重要因素。

如何訪問

人工血管置於皮下，必須使用輸液港穿刺針從皮膚表面進行穿刺。這種獨特的穿刺方式可能會讓某些患者感到不舒服。

穿刺輸液港需要相當大的力氣，而且可能會很痛。輸液港針頭一旦插入，通常會在輸液治療期間留在原位，這可能會造成進一步的不適。

基於這些使用經驗，有些患者可能會選擇其他靜脈通路裝置。這限制了輸液港的廣泛應用，尤其對於需要頻繁輸液且專注於疼痛和舒適度的患者。

動力注射端口價格溢價降低

電源注入式連接埠價格溢價的下降可能會限制市場價值成長。最初，電源注入功能相比傳統連接埠具有明顯的實用優勢，因此平均售價更高。

然而，隨著可注入電源介面逐漸成為標準配置，價格差異正在逐漸縮小。這正在削弱先前採用高階功能所帶來的成長優勢。

未來市場表現將越來越依賴注射劑的普及，不僅取決於注射劑的普及程度，還取決於臨床偏好、替代需求、治療效果和產品差異化。這將使製造商更難僅依靠高價策略來推動價值成長。

市場範圍和數據範圍

  • 量化範圍：市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售單位數量、平均售價。
  • 定性範圍：市場促進因素和阻礙因素、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
  • 目標時期：基準年為 2025 年，預測至 2032 年，歷史資料截至 2022 年。
  • 建立市場模型：收入分析採用銷售量和平均售價（ASP），並輔以治療量、競爭市場佔有率分析和預測假設。
  • 目標器械：本報告涵蓋用於長期血管通路的人工血管。這包括電動充氣式和非電動充氣式輸液港、單腔和雙腔輸液港、帶瓣和無瓣輸液港，以及抗血栓和常規器械類型。

目標市場及區隔

人工血管市場

  • 設備類型：電動充氣式和非電動充氣式。

高壓注射端口的設計旨在承受CT成像過程中造影劑注射所需的高壓。隨著與影像技術的兼容性變得越來越重要，這些裝置在許多醫療機構中變得越來越普遍。

無動力輸液港是用於液體治療和長期血管通路的常規人工血管，但它們並非設計用於高壓造影劑輸注。

  • 管腔類型：單管腔和雙管腔。

單腔端口可滿足標準輸液需求，而雙腔端口可透過單獨的通道輸注多種藥物或治療方法。

  • 閥門類型：帶閥和不帶閥。

帶瓣端口旨在減少血液逆流和相關併發症，但對於注重成本的市場和標準使用場景，無瓣端口仍然可用。

  • 設備特性：抗血栓和常規。

雖然抗血栓端口旨在抑制血栓形成，但傳統端口在市場上也被廣泛應用。

每個細分市場都按市場規模、市場佔有率、治療數量、市場預測、市場成長率、銷售量和平均售價進行分析。

競爭分析

2025年，貝克頓·迪金森公司憑藉其PowerPort®系列產品，持續保持在全球人工血管市場的領先地位。該公司的產品系列包括緊湊型鈦合金PowerPort® Slim和PowerPort® MRI®，後者旨在減少對診斷成像的干擾。

BD也提供非電動輸液產品，例如用於多藥聯合輸注的SlimPort™雙腔Rosenblatt™輸液器和適用於體型較小患者的X-Port™輸液器。此外，該公司還提供帶有閥門的輸液系統，例如AirGuard™和Groshong™，這些系統旨在減少血液逆流和併發症，從而進一步豐富其產品線。

2025年，AngioDynamics在全球嵌入式輸液港市場佔了相當大的佔有率。該公司的產品線包括Xcela® Plus、BioFlo®、Smart Port®、Vortex®、LifePort®、TitanPort®和Triumph-1®。

該公司推出了Smart Port CT™，該產品整合了Vortex®技術，可改善引流並降低導管阻塞和感染的風險。 AngioDynamics也提供採用Endexo技術的BioFlo Port，該導管使用特殊材料，與未塗層導管相比，可防止血液成分在體外積聚。

2025年，ICU Medical在人工血管市場佔第三大市場。其PORT-A-CATH®品牌廣為人知，新款PORT-A-CATH II®採用聚碸和鈦合金混合結構，確保在核磁共振成像（MRI）下具有良好的安全性和耐用性。 ICU Medical也提供PAS PORT®手臂系列輸液港和可植入胸部或上臂的高壓輸液港；然而，由於擔心導管夾傷，上臂輸液港的普及程度並未達到預期。

技術與臨床實務的趨勢

高壓注射相容連接埠的廣泛應用

高壓注射端口正在許多醫療機構中成為標準配置，因為它們支援使用造影劑的 CT 影像診斷工作流程。

隨著這些設備越來越普及，價格差距有望縮小，未來的成長將主要取決於臨床偏好和更換需求。

抗菌技術創新

製造商正致力於改進抗菌材料、表面塗層和設計，以降低感染風險。

雖然與許多其他靜脈通路裝置相比，輸液港的感染風險已經較低，但進一步的改進可以增強其相對於 PICC 導管和慢性血管靜脈導管 (CVC) 的優勢。

帶閥門的端口系統

帶閥端口旨在減少血液逆流及相關併發症。這些系統可提高臨床應用的可靠性，並有助於產品在高級產品類別中脫穎而出。

在注重成本的市場中，無閥端口仍然是一個重要的選擇。

替代拘留策略

周邊和上臂植入策略仍在不斷探索中，尤其是在某些腫瘤學領域。這些方法旨在減輕手術負擔並擴大患者的選擇範圍。

然而，由於擔心患者移動或體位變化會導致導管被擠壓，因此在手臂上廣泛採用輸液港植入術仍面臨挑戰。

抗血栓材料

Endexo等技術旨在減少血液成分與導管材料的黏附。這些特性可望降低導管阻塞的風險，並提高導管的長期性能。

隨著高壓注射技術的標準化，該領域的產品差異化可能變得更加重要。

患者生活方式的考慮

選擇輸液港時，患者的生活方式仍然是至關重要的因素。人工血管在不使用時從外部是看不見的。這有助於提高接受長期治療患者的舒適度、活動能力和日常活動。

這使得希望隱蔽使用輸液港且減少日常限制的患者繼續支持輸液港。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。

這份報告的意義

  • 全球人工血管市場目前的規模有多大？預計到 2032 年將成長多少？
  • 隨著時間的推移，銷售量、治療量、平均售價（ASP）和市場規模發生了什麼樣的變化？
  • 電動輸液端口如何改變產品配置以及與成像設備的兼容性？
  • 為什麼電動注油介面的價格溢價正在下降？
  • 病患的偏好如何影響人工血管相對於體外靜脈通路裝置的使用？
  • 抗菌材料、塗層和設計改進在港口創新中發揮著怎樣的作用？
  • 不同的端口配置（帶閥門、不帶閥門、單腔、雙腔）在市場需求方面有何不同？
  • 根據植入手術方法或連接埠進入方式的不同，會出現哪些類型的障礙？
  • 哪家公司在全球人工血管市場處於領先地位？
  • BD、AngioDynamics 和 ICU Medical 在電輸液港、非電輸液港、帶瓣膜港和專用港這幾類產品中分別屬於哪一類？

iData Research 的「全球植入式端口市場報告」透過設備層級分析、基於手術的建模、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。本報告可用於評估需求、與競爭對手進行基準比較、了解高壓注射相容產品的滲透率，並協助您制定全球植入式連接埠市場的產業計畫。

目錄

調查方法

  • 第一步：專案啟動與團隊組建
  • 步驟 2：準備資料系統並進行二次調查。
  • 步驟 3：設計和準備訪談和調查問卷。
  • 第四步：進行初步調查
  • 第五步：調查與分析：建立基準估計值
  • 第六步：市場預測與分析
  • 步驟 7：辨識策略機遇
  • 步驟 8：最終審核和市場推廣
  • 步驟九：客戶回饋與市場監測

全球關稅的影響

人工血管市場

  • 摘要整理
    • 全球人工血管市場概覽
    • 競爭分析
    • 目標程式
    • 目標市場
    • 目標區域
  • 介紹
  • 手術次數
    • 完全人工血管手術
  • 市場概覽
    • 按細分市場
    • 按閥門類型
    • 按設備屬性
    • 按地區
  • 市場分析與預測
    • 整體人工血管市場
    • 人工血管市場區隔分析
    • 按流明數分類的凹陷端口市場
    • 按閥門類型分類的人工血管市場
    • 人工血管市場（依設備特性分類）
  • 促進因素和抑制因素
  • 競爭性市佔率分析
Product Code: iDATA_GLVA26_IM_MC

Global Implantable Port Market Report to 2032

The global implantable port market was valued slightly above $430 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 3.0%, reaching approximately $530 million by 2032.

This report covers the global market for implantable ports, including non-power-injectable and power-injectable implantable ports used for long-term vascular access.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by the adoption of power-injectable ports, patient preference for fully implanted access, and ongoing design improvements. However, implantation cost, procedural burden, access discomfort, and competition from alternative vascular access devices continue to limit stronger expansion.

Market Overview

The global implantable port market includes long-term vascular access devices implanted beneath the skin. These products are commonly used for patients requiring repeated infusion therapy, including oncology patients receiving chemotherapy.

The market includes power-injectable and non-power-injectable implantable ports. Power-injectable ports can withstand higher pressures than conventional ports, allowing contrast dye injection for computed tomography scan procedures.

If a patient has a conventional implantable port and later requires certain medical imaging workflows, the port may need to be removed and replaced with a power-injectable port. This has supported the shift toward power-injectable technology as a preferred option in many care settings.

Ongoing technological developments are improving the clinical profile of implantable ports and expanding their use cases. Innovation is focused on antimicrobial materials, surface coatings, design improvements, and alternative placement strategies, positioning ports as a more competitive option against PICCs and chronic CVCs in selected indications.

Market Drivers

Power-Injectable Ports

Power-injectable ports are a key driver of the implantable port market. Unit sales of plastic and hybrid power-injectable ports are expected to increase over the forecast period.

These devices support contrast-enhanced imaging workflows and are increasingly expected in many care settings. Their ability to withstand higher injection pressures makes them more flexible for patients who may need both infusion therapy and imaging procedures.

The shift to power-injectable ports has helped stabilize market dynamics by supporting demand for higher-value products. However, this effect is expected to normalize as power-injectable ports become standard of care and the premium commanded by these devices continues to narrow.

Patient Preferences

Patient preference is another important driver. Patients undergoing chemotherapy often want to remain active during treatment, and implantable ports offer lifestyle advantages over external vascular access devices.

Unlike many alternative devices, implantable ports are not visible externally when not accessed. This can make them more appealing to patients who want to maintain daily activities with fewer restrictions.

External devices can limit mobility and may interfere with swimming, showering, or other activities that could dislocate the device or compromise sterility. As the population ages, more potential port patients are expected to have both the need and the means to choose implantable ports over alternative access devices.

Technology and Design Improvements

Technology and design improvements are supporting continued demand for implantable ports. Manufacturers are focusing on features that reduce infection risk, improve access reliability, and support long-term use.

Although implantable ports already have a low infection risk relative to many other vascular access devices, companies are investing in antimicrobial materials, surface coatings, and design enhancements.

Growing interest in alternative placement strategies, including peripheral approaches tailored to specific oncology applications, also reflects efforts to reduce procedural burden. These improvements support clinical preference and help implantable ports remain competitive against PICCs and chronic CVCs.

Market Limiters

Implantation Procedure

The implantation procedure is a significant limiter in the implantable port market. Port placement usually requires a procedure involving anesthesia and operating room time, which makes it more expensive than many alternative vascular access options.

The need for a procedural setting can create barriers for patients, providers, and healthcare systems. This is especially important in cost-sensitive environments where less expensive access devices may be preferred.

Implantation can also result in complications, including infections in patients with compromised immune systems. Although ports generally have favorable infection profiles, procedural risk remains an important factor when deciding between port placement and alternative access methods.

Access Method

Implantable ports are installed beneath the skin and must be accessed through the skin surface using a port needle. This unique access method can create discomfort for some patients.

Penetrating the port requires a significant amount of force, which can be painful. Once the port needle is inserted, it is often left in place during infusion therapy and may cause additional discomfort.

Because of this access experience, some patients may choose alternative vascular access devices. This limits broader adoption, especially when the patient requires frequent access and has concerns about pain or comfort.

Narrowing Power-Injectable Premium

The narrowing price premium for power-injectable ports may limit market value growth. Power capability initially supported higher ASPs because these devices offered a clear functional advantage over conventional ports.

However, as power-injectable ports become standard practice, pricing differentiation is gradually narrowing. This reduces the growth benefit that came from premium feature adoption.

Future market performance will increasingly depend on clinical preference, replacement demand, procedural efficiency, and product differentiation rather than power-injectable conversion alone. This makes it more difficult for manufacturers to rely only on premium pricing to drive value growth.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
  • Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
  • Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
  • Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
  • Device scope: The report covers implantable ports used for long-term vascular access, including power-injectable and non-power-injectable ports, single-lumen and double-lumen ports, valved and non-valved ports, and antithrombogenic and conventional device types.

Markets Covered and Segmentation

Implantable Port Market

  • Device type: Power-injectable and non-power-injectable.

Power-injectable ports are designed to withstand higher pressures for contrast dye injection during CT imaging procedures. These devices are becoming more common as imaging compatibility becomes an expected feature in many care settings.

Non-power-injectable ports are conventional implantable ports used for infusion therapy and long-term vascular access but not designed for high-pressure contrast injection.

  • By lumen: Single lumen and double lumen.

Single-lumen ports support standard infusion needs, while double-lumen ports allow multiple therapies or medications to be delivered through separate access channels.

  • By valve type: Valved and non-valved.

Valved ports are designed to reduce blood reflux and related complications, while non-valved ports remain available for cost-sensitive markets and standard use cases.

  • Device properties: Antithrombogenic and conventional.

Antithrombogenic ports are designed to reduce thrombus formation, while conventional ports remain widely used in the market.

Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

Competitive Analysis

In 2025, Becton Dickinson maintained its leadership in the global implantable port market through its PowerPort(R) line. The portfolio includes the compact titanium PowerPort(R) Slim and PowerPort(R) MRI(R), which is designed to reduce imaging interference.

BD also offers non-power-injectable products such as the SlimPort(TM) Dual-Lumen Rosenblatt(TM) for multi-medication infusion and the X-Port(TM) for smaller patients. The company further differentiates its offering with valved systems such as AirGuard(TM) and Groshong(TM), which are designed to reduce blood reflux and complications.

AngioDynamics held a significant share of the global implantable port market in 2025. Its portfolio includes Xcela(R) Plus, BioFlo(R), Smart Port(R), Vortex(R), LifePort(R), TitanPort(R), and Triumph-1(R).

The company introduced Smart Port CT(TM) with integrated Vortex(R) technology to enhance drainage and reduce catheter occlusion and infection risk. AngioDynamics also offers the BioFlo Port with Endexo Technology, which uses catheter material designed to resist in-vitro accumulation of blood components compared with non-coated port catheters.

ICU Medical ranked third in the implantable port market in 2025. Its PORT-A-CATH(R) brand is widely recognized, and the newer PORT-A-CATH II(R) model uses a hybrid polysulfone and titanium construction for MRI safety and durability. ICU Medical also offers the P.A.S. PORT(R) arm series and power-injectable ports for chest or arm placement, although arm ports have not gained as much popularity as expected due to catheter pinching concerns.

Technology and Practice Trends

Power-Injectable Port Adoption

Power-injectable ports are becoming standard in many care settings because they support contrast-enhanced CT imaging workflows.

As these devices become more common, their pricing premium is expected to narrow, making future growth more dependent on clinical preference and replacement demand.

Antimicrobial Innovation

Manufacturers are focusing on antimicrobial materials, surface coatings, and design enhancements to reduce infection risk.

Although ports already have a lower infection risk than many alternative vascular access devices, further improvements could strengthen their position against PICCs and chronic CVCs.

Valved Port Systems

Valved ports are designed to reduce blood reflux and related complications. These systems can improve clinical confidence and support differentiation in premium product categories.

Non-valved ports remain relevant in cost-sensitive markets.

Alternative Placement Strategies

Peripheral and arm placement strategies continue to be explored, especially for certain oncology applications. These approaches aim to reduce procedural burden and improve patient options.

However, arm ports have faced adoption challenges due to concerns around catheter pinching based on patient movement and positioning.

Thrombus-Resistant Materials

Technologies such as Endexo are designed to reduce accumulation of blood components on catheter materials. These features may support lower occlusion risk and improve long-term device performance.

Product differentiation in this area may become more important as power-injectable capability becomes standard.

Patient Lifestyle Considerations

Patient lifestyle remains important in port selection. Implantable ports are not visible externally when not accessed, which can improve comfort, mobility, and daily activity for patients receiving long-term therapy.

This supports continued preference for ports among patients who want less visible access and fewer daily restrictions.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

  • How large is the global implantable port market today, and how much is it expected to grow through 2032?
  • How are unit sales, procedure numbers, ASPs, and market values changing over time?
  • How are power-injectable ports changing product mix and imaging compatibility?
  • Why is the pricing premium for power-injectable ports narrowing?
  • How do patient preferences support the use of implantable ports over external vascular access devices?
  • What role do antimicrobial materials, coatings, and design improvements play in port innovation?
  • How do valved, non-valved, single-lumen, and double-lumen ports differ in market demand?
  • What barriers are created by the implantation procedure and port access method?
  • Which companies lead the global implantable port market?
  • How are BD, AngioDynamics, and ICU Medical positioned across power-injectable, non-power-injectable, valved, and specialty port categories?

The Global Implantable Port Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand power-injectable adoption, and support commercial planning in the global implantable port market.

TABLE OF CONTENT

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Implantable Port Market

  • 4.1 Executive Summary
    • 4.1.1 Global Implantable Port Market Overview
    • 4.1.2 Competitive Analysis
    • 4.1.3 Procedures Included
    • 4.1.4 Markets Included
    • 4.1.5 Regions Included
  • 4.2 Introduction
  • 4.3 Procedure Numbers
    • 4.3.1 Total Implantable Port Procedures
      • 4.3.1.1 Power-Injectable Procedures
      • 4.3.1.2 Non-Power-Injectable Procedures
  • 4.4 Market Overview
    • 4.4.1 By Segment
    • 4.4.2 By Valve Type
    • 4.4.3 By Device Properties
    • 4.4.4 By Region
  • 4.5 Market Analysis And Forecast
    • 4.5.1 Total Implantable Port Market
    • 4.5.2 Implantable Port Market By Segment
      • 4.5.2.1 Power-Injectable Implantable Port Market
      • 4.5.2.2 Non-Power-Injectable Implantable Port Market
    • 4.5.3 Implantable Port Market By Lumen Count
      • 4.5.3.1 Single-Lumen Implantable Port Market
      • 4.5.3.2 Double-Lumen Implantable Port Market Implantable Port Market
    • 4.5.4 Implantable Port Market By Valve Type
      • 4.5.4.1 Valved Implantable Port Market
      • 4.5.4.2 Non-Valved Implantable Port Market
    • 4.5.5 Implantable Port Market By Device Properties
      • 4.5.5.1 Antithrombogenic Implantable Port Market
      • 4.5.5.2 Conventional Implantable Port Market
  • 4.6 Drivers And Limiters
    • 4.6.1 Market Drivers
    • 4.6.2 Market Limiters
  • 4.7 Competitive Market Share Analysis

LIST OF CHARTS

  • Chart 4-1: Implantable Port Market, Global, 2025 & 2032
  • Chart 4-2: Implantable Port Procedures, Global, 2025
  • Chart 4-3: Implantable Port Procedures by Region, Global, 2022 - 2032
  • Chart 4-4: Implantable Port Market by Segment, Global, 2022 - 2032
  • Chart 4-5: Implantable Port Market by Region, Global, 2022 - 2032
  • Chart 4-6: Leading Competitors, Implantable Port Market, Global, 2025

LIST OF FIGURES

  • Figure 4-1: Implantable Port Procedures Covered
  • Figure 4-2: Implantable Port Markets Covered
  • Figure 4-3: Implantable Port Regions Covered, Global (1 of 2)
  • Figure 4-4: Implantable Port Regions Covered, Global (2 of 2)
  • Figure 4-5: Implantable Port Procedures by Region, Global, 2022 - 2032
  • Figure 4-6: Implantable Port Procedures by Country, North America, 2022 - 2032
  • Figure 4-7: Implantable Port Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 4-8: Implantable Port Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 4-9: Implantable Port Procedures by Country, Western Europe, 2022 - 2032
  • Figure 4-10: Implantable Port Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 4-11: Implantable Port Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 4-12: Implantable Port Procedures by Country, Middle East, 2022 - 2032
  • Figure 4-13: Implantable Port Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 4-14: Implantable Port Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 4-15: Implantable Port Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 4-16: Implantable Port Procedures by Country, Africa, 2022 - 2032
  • Figure 4-17: Power-Injectable Procedures by Region, Global, 2022 - 2032
  • Figure 4-18: Power-Injectable Procedures by Country, North America, 2022 - 2032
  • Figure 4-19: Power-Injectable Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 4-20: Power-Injectable Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 4-21: Power-Injectable Procedures by Country, Western Europe, 2022 - 2032
  • Figure 4-22: Power-Injectable Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 4-23: Power-Injectable Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 4-24: Power-Injectable Procedures by Country, Middle East, 2022 - 2032
  • Figure 4-25: Power-Injectable Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 4-26: Power-Injectable Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 4-27: Power-Injectable Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 4-28: Power-Injectable Procedures by Country, Africa, 2022 - 2032
  • Figure 4-29: Non-Power-Injectable Procedures by Region, Global, 2022 - 2032
  • Figure 4-30: Non-Power-Injectable Procedures by Country, North America, 2022 - 2032
  • Figure 4-31: Non-Power-Injectable Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 4-32: Non-Power-Injectable Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 4-33: Non-Power-Injectable Procedures by Country, Western Europe, 2022 - 2032
  • Figure 4-34: Non-Power-Injectable Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 4-35: Non-Power-Injectable Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 4-36: Non-Power-Injectable Procedures by Country, Middle East, 2022 - 2032
  • Figure 4-37: Non-Power-Injectable Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 4-38: Non-Power-Injectable Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 4-39: Non-Power-Injectable Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 4-40: Non-Power-Injectable Procedures by Country, Africa, 2022 - 2032
  • Figure 4-41: Implantable Port Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 4-42: Implantable Port Market by Valve type, Global, 2022 - 2032 (US$M)
  • Figure 4-43: Implantable Port Market by Device Properties, Global, 2022 - 2032 (US$M)
  • Figure 4-44: Implantable Port Market by Region, Global, 2022 - 2032 (US$M)
  • Figure 4-45: Implantable Port Maret, Global, 2022 - 2032
  • Figure 4-46: Units Sold by Region, Implantable Port Market, Global, 2022 - 2032
  • Figure 4-47: Average Selling Price by Region, Implantable Port Market, Global, 2022 - 2032 (US$)
  • Figure 4-48: Market Value by Region, Implantable Port Market, Global, 2020 - 2030 (US$M)
  • Figure 4-49: Units Sold by Region, Power-Injectable Implantable Port Market, Global, 2022 - 2032
  • Figure 4-50: Average Selling Price by Region, Power-Injectable Implantable Port Market, Global, 2022 - 2032 (US$)
  • Figure 4-51: Market Value by Region, Power-Injectable Implantable Port Market, Global, 2022 - 2032 (US$M)
  • Figure 4-52: Power Injectable Implantable Port Market, Global, 2022 - 2032
  • Figure 4-53: Units Sold by Region, Power-Injectable Implantable Port Market, Global, 2022 - 2032
  • Figure 4-54: Average Selling Price by Region, Power-Injectable Implantable Port Market, Global, 2022 - 2032 (US$)
  • Figure 4-55: Market Value by Region, Power-Injectable Implantable Port Market, Global, 2022 - 2032 (US$M)
  • Figure 4-56: Total Non-Power Injectable Implantable Port Market, Global, 2022 - 2032
  • Figure 4-57: Units Sold by Region, Non-Power-Injectable Implantable Port Market, Global, 2022 - 2032
  • Figure 4-58: Average Selling Price by Region, Non-Power-Injectable Implantable Port Market, Global, 2022 - 2032 (US$)
  • Figure 4-59: Market Value by Region, Non-Power-Injectable Implantable Port Market, Global, 2022 - 2032 (US$M)
  • Figure 4-60: Total Single-Lumen Implantable Port Market, Global, 2022 - 2032
  • Figure 4-61: Units Sold by Region, Single-Lumen Implantable Port Market, Global, 2022 - 2032
  • Figure 4-62: Average Selling Price by Region, Single-Lumen Implantable Port Market, Global, 2022 - 2032 (US$)
  • Figure 4-63: Market Value by Region, Single-Lumen Implantable Port Market, Global, 2022 - 2032 (US$M)
  • Figure 4-64: Total Double-Lumen Implantable Port Market, Global, 2022 - 2032
  • Figure 4-65: Units Sold by Region, Double-Lumen Implantable Port Market, Global, 2022 - 2032
  • Figure 4-66: Average Selling Price by Region, Double-Lumen Implantable Port Market, Global, 2022 - 2032 (US$)
  • Figure 4-67: Market Value by Region, Double-Lumen Implantable Port Market, Global, 2022 - 2032 (US$M)
  • Figure 4-68:Total Implantable Port By Valved Type Market, Global, 2022 - 2032
  • Figure 4-69: Units Sold by Region, Implantable Port By Valved Type Market, Global, 2022 - 2032
  • Figure 4-70: Average Selling Price by Region, Implantable Port By Valved Type Market, Global, 2022 - 2032 (US$)
  • Figure 4-71: Market Value by Region, Implantable Port By Valved Type Market, Global, 2022 - 2032 (US$M)
  • Figure 4-72: Total Non-Valved Implantable Port Market, Global, 2022 - 2032
  • Figure 4-73: Units Sold by Region, Non-Valved Implantable Port Market, Global, 2022 - 2032
  • Figure 4-74: Average Selling Price by Region, Non-Valved Implantable Port Market, Global, 2022 - 2032 (US$)
  • Figure 4-75: Market Value by Region, Non-Valved Implantable Port Market, Global, 2022 - 2032 (US$M)
  • Figure 4-76: Total Antithrombogenic Implantable Port Market, Global, 2022 - 2032
  • Figure 4-77: Units Sold by Region, Antithrombogenic Implantable Port Market, Global, 2022 - 2032
  • Figure 4-78: Average Selling Price by Region, Antithrombogenic Implantable Port Market, Global, 2022 - 2032 (US$)
  • Figure 4-79: Market Value by Region, Antithrombogenic Implantable Port Market, Global, 2022 - 2032 (US$M)
  • Figure 4-80: Total Conventional Implantable Port Market, Global, 2022 - 2032
  • Figure 4-81: Units Sold by Region, Conventional Implantable Port Market, Global, 2022 - 2032
  • Figure 4-82: Average Selling Price by Region, Conventional Implantable Port Market, Global, 2022 - 2032 (US$)
  • Figure 4-83: Market Value by Region, Conventional Implantable Port Market, Global, 2022 - 2032 (US$M)
  • Figure 4-84: Leading Competitors, Implantable Port Market, Global, 2025